Langerhans cell histiocytosis: Version 2021.
Ontology highlight
ABSTRACT: Children with Langerhnans cell histiocytosis (LCH) develop granulomatous lesions with characteristic clonal CD207+ dendritic cells that can arise as single lesions or life-threatening disseminated disease. Despite the wide range of clinical presentations, LCH lesions are histologically indistinguishable based on severity of disease, and uncertain classification as an immune versus neoplastic disorder has historically challenged the development of optimal clinical strategies for patients with LCH. Recently, activating somatic mutations in MAPK pathway genes, most notably BRAFV600E, have been discovered in almost all cases of LCH. Further, the stage of myeloid differentiation in which the mutation arises defines the extent of disease and risk of developing LCH-associated neurodegeneration. M
SUBMITTER: Gulati N
PROVIDER: S-EPMC9150752 | biostudies-literature | 2021 Jun
REPOSITORIES: biostudies-literature
ACCESS DATA